[Cambendazole - a new substance for the treatment of strongyloidiasis].
The Author studied the therapeutic activity of a new drug - Cambendazole, in the treatment of 100 children suffering from strongyloidiasis infection. The patients received a single dose of the 5 mg per K of body weight, and laboratorial controls were made in the 7th, 8th, 9th, and 10th after the treatment and consisting of Berman-Moraes method.